ArticleClinical research in cardiology : official journal of the German Cardiac Society2025
The association of heart rate with adverse outcomes and recurrent heart failure hospitalization in peripartum cardiomyopathy.
Article in Clinical research in cardiology : official journal of the German Cardiac Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
introductionUnderstanding predictors of adverse outcomes in patients with peripartum cardiomyopathy (PPCM) is essential for risk stratification and prognosis. The aim of this study is to examine the relationship between heart rate (HR) at diagnosis and adverse outcomes in PPCM.
methodsWe conducted a multi-center cohort study to identify patients with PPCM (1993-2017) who met the inclusion criteria: left ventricular ejection fraction (LVEF) <40%, development of heart failure within the last month of pregnancy or within 5 months of delivery, and no other identifiable cause of heart failure with reduced ejection fraction. The primary composite outcome of major adverse events included recurrent heart failure hospitalization, need for extra-corporeal membrane oxygenation, left ventricular assist device, orthotopic heart transplant, or all-cause death. Using Cox proportional hazards models, we examined the relationship between categories of HR at diagnosis and adverse outcomes.
resultsA total of 177 women met criteria (81 with HR <100 bpm, 54 with HR 100-119 bpm, 42 with HR ≥120 bpm) with a mean age of 32 ± 7 years and median follow-up 3.6 years (IQR 1.1-8.2); 48 (27%) experienced the composite outcome. In a multivariable model adjusting for age, race, preeclampsia and hypertension, women with HR ≥ 120 bpm were four times more likely to experience major adverse events compared to women with HR < 100 bpm (HR 4.1, 95% CI 1.6-10.4) at the time of diagnosis. In a second multivariable model adjusting for the above covariates plus LVEF < 30%, QTc, and systolic blood pressure, those with HR ≥ 120 bpm were more likely to experience major adverse events compared to those with HR < 100 bpm (HR 3.31 (1.01-10.9), p = 0.049). Patients with HR <100 bpm were significantly more likely to have survival free from adverse events in survival analysis (p = 0.03).
conclusionSinus tachycardia at diagnosis was associated with lower LVEF on presentation and higher rates of major adverse events in PPCM. Tachycardia may be an early prognostic indicator of outcomes in PPCM and could help identify high-risk patients for closer follow-up and earlier intervention.
Indexed as
Identifiers
39992386What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.